The impact of pharmacologic sympathetic and parasympathetic blockade on atrial electrogram characteristics in patients with atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 11, 2011, Pages 1460-1467

  Habel, Nicole ^a,d   MÜller, Joachim G ^a,b   Znojkiewicz, Pierre ^a,b   Thompson, Nathaniel ^a   Calame, James ^a,b   Calame, Susan ^b   Noori, Arshia ^a,b   Gallo, Annemarie ^c   Lustgarten, Daniel L ^a,b,d   Sobel, Burton E ^a,b,d   Spector, Peter S ^a,b,d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d Cardiovascular Research Institute   (United States)

Author keywords

atrial fibrillation; atropine; dominant frequency; electrogram characteristics; esmolol; fractionation; ganglionated plexi; multisite simultaneous mapping; pharmacologic autonomic blockade

Indexed keywords

ATROPINE; ESMOLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; DOMINANT FREQUENCY; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; FRACTIONATION; FREQUENCY MODULATOR; HEART ATRIUM FIBRILLATION; HEART MUSCLE POTENTIAL; HUMAN; MALE; PARASYMPATHETIC FUNCTION; PHARMACOLOGIC AUTONOMIC BLOCKADE; SPATIAL FREQUENCY DISCRIMINATION; SYMPATHETIC BLOCKING;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ATRIAL FIBRILLATION; ATROPINE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NERVE BLOCK; PARASYMPATHOLYTICS; PROPANOLAMINES; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS; TREATMENT OUTCOME;

EID: 81055156167     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03212.x     Document Type: Article

References (25)

1. Wilson RM, Mackenzie J. In:, Willius FA, Keys TE, (eds.) Classics of Cardiology. Vol 2. Malabar, FL, Robert E. Krieger Publishing Company, 1983, pp. 765-768.
2. Loewi O,. On humoral transmission of cardiac-nerve impulses. Arch Ges Physiol 1921; 189: 239-242.
3. Rushmer RF,. Functional Anatomy and Control of the Heart. Cardiovascular Dynamics, 4th ed. Philadephia: W.B. Saunders Company; 1976.
4. Shepherd JT, Vanhoutte PM,. Neurohumoral Regulation. The Human Cardiovascular System, Facts and Concepts. New York, Raven Press; 1979.
5. Patterson E, Po SS, Scherlag BJ, Lazzara R,. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2005; 2: 624-631. (Pubitemid 40724130)
6. Lu Z, Scherlag BJ, Niu G, Lin J, Fung KM, Zhao L, Yu L, et al,. Functional properties of the superior vena cava (SVC)-aorta ganglionated plexus: Evidence suggesting an autonomic basis for rapid SVC firing. J Cardiovasc Electrophysiol 2010; 21: 1392-1399.
7. Lin J, Scherlag BJ, Lu Z, Zhang Y, Liu S, Patterson E, Jackman WM, et al,. Inducibility of atrial and ventricular arrhythmias along the ligament of marshall: Role of autonomic factors. J Cardiovasc Electrophysiol 2008; 19: 955-962.
8. Alessi R, Nusynowitz M, Abildskov JA, Moe GK,. Nonuniform distribution of vagal effects on the atrial refractory period. Am J Physiol 1958; 194: 406-410.
9. Zipes DP, Mihalick MJ, Robbins GT,. Effects of selective vagal and stellate ganglion stimulation of atrial refractoriness. Cardiovasc Res 1974; 8: 647-655.
10. Henning RJ, Sawmiller DR,. Vasoactive intestinal peptide: Cardiovascular effects. Cardiovasc Res 2001; 49: 27-37.
11. Scherlag BJ, Nakagawa H, Jackman WM, Yamanashi WS, Patterson E, Po S, Lazzara R,. Electrical stimulation to identify neural elements on the heart: Their role in atrial fibrillation. J Interv Card Electrophysiol 2005; 13 (Suppl 1): 37-42. (Pubitemid 41225155)
12. Scherlag BJ, Patterson E, Po SS,. The neural basis of atrial fibrillation. J Electrocardiol 2006; 39 (4 Suppl): S180-S183. (Pubitemid 44465943)
13. Spector PS, Noori AM, Hardin NJ, Calame JD, Bell SP, Lustgarten DL,. Pulmonary vein encircling ablation alters the atrial electrophysiologic response to autonomic stimulation. J Interv Card Electrophysiol 2006; 17: 119-125. (Pubitemid 46434825)
14. Habel N, Znojkiewicz P, Thompson N, Müller JG, Noori A, Calame J, Calame S, et al,. Effects of pharmacologic autonomic blockade on frequency and fractionation in human AF. Heart Rhythm 2010; 7: 41 (Abstract).
15. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the management of patients with atrial fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354. (Pubitemid 44252297)
16. Sanders P, Berenfeld O, Hocini M, Jais P, Vaidyanathan R, Hsu LF, Garrigue S, et al,. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 2005; 112: 789-797. (Pubitemid 41170063)
17. Takahashi Y, O'Neill MD, Hocini M, Dubois R, Matsuo S, Knecht S, Mahapatra S, et al,. Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol 2008; 51: 1003-1010. (Pubitemid 351318134)
18. Katritsis D, Sougiannis D, Batsikas K, Giazitzoglou E, Mersinias J, Katritsis G, Po SS,. Autonomic modulation of complex fractionated atrial electrograms in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol 2011; 31: 217-223.
19. Habel N, Znojkiewicz P, Thompson N, Müller JG, Mason B, Calame J, Calame S, et al,. The temporal variability of dominant frequency and complex fractionated atrial electrograms constrains the validity of sequential mapping in human atrial fibrillation. Heart Rhythm 2010; 7: 586-593.
20. Knecht S, Wright M, Matsuo S, Nault I, Lellouche N, Sacher F, Kim SJ, et al,. Impact of pharmacological autonomic blockade on complex fractionated atrial electrograms. J Cardiovasc Electrophysiol 2010; 21: 766-772.
21. Habel N, Znojkiewicz P, Karnbach A, Karnbach A, Sobel BE, Bates JHT, Spector PS,. Dissociation between electrogram frequency and tissue frequency. Heart Rhythm 2010; 7: 350 (Abstract).
22. Hirose M, Leatmanoratn Z, Laurita KR, Carlson MD,. Partial vagal denervation increases vulnerability to vagally induced atrial fibrillation. J Cardiovasc Electrophysiol 2002; 13: 1272-1279. (Pubitemid 36042727)
23. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, et al,. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004; 109: 327-334. (Pubitemid 38133899)
24. Pokushalov E, Romanov A, Shugayev P, Artyomenko S, Shirokova N, Turov A, Katritsis DG,. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm 2009; 6: 1257-1264.
25. Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, Camm AJ,. Rapid pulmonary vein isolation combined with autonomic ganglia modification: A randomized study. Heart Rhythm 2011; 8: 672-678.